Market Access Views & Analysis

Views & Analysis

Market Access

At the Biotech Showcase during JPM Week, biotech leaders expressed frustration at the US's lack of concern about Chinese biotech progress.

Market Access

If Europe can bridge its operational gaps while leveraging its scientific base, it can carve out a distinctive and sustainable leadership position.

Market Access

JP Morgan Week may not have produced megadeals this year, but it still yielded plenty of food for thought. Here's five quick insights from San Fran.

Market Access

Europe and the United Kingdom are entering a period of direct exposure to US policy choices, and the implications are significant and immediate.

Market Access

Some may argue that VCs and public markets have turned against biotech, but the reality is they have become much more sceptical.

Market Access

Whatever people think of changes to the UK’s pricing deal, VPAG, judging the difference they make should include monitoring non-submissions to NICE.